Found: 5
Select item for more details and to access through your institution.
Multifaceted Intervention by the Hsp90 Inhibitor Ganetespib (STA-9090) in Cancer Cells with Activated JAK/STAT Signaling.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0018552
- By:
- Publication type:
- Article
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 577, doi. 10.1007/s10637-014-0095-4
- By:
- Publication type:
- Article
Targeted inhibition of Hsp90 by ganetespib is effective across a broad spectrum of breast cancer subtypes.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 1, p. 14, doi. 10.1007/s10637-013-9971-6
- By:
- Publication type:
- Article
Synergistic activity of the Hsp90 inhibitor ganetespib with taxanes in non-small cell lung cancer models.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2201, doi. 10.1007/s10637-011-9790-6
- By:
- Publication type:
- Article
The HSP90 inhibitor ganetespib potentiates the antitumor activity of EGFR tyrosine kinase inhibition in mutant and wild-type non-small cell lung cancer.
- Published in:
- Targeted Oncology, 2015, v. 10, n. 2, p. 235, doi. 10.1007/s11523-014-0329-6
- By:
- Publication type:
- Article